|
1
|
Volpin E, Sauvanet A, Couvelard A and
Belghiti J: Primary malignant melanoma of the esophagus: A case
report and review of the literature. Dis Esophagus. 15:244–249.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iwanuma Y, Tomita N, Amano T, Isayama F,
Tsurumaru M, Hayashi T and Kajiyama Y: Current status of primary
malignant melanoma of the esophagus: Clinical features, pathology,
management and prognosis. J Gastroenterol. 47:21–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao S, Li J, Feng X, Shi S and He J:
Characteristics and surgical outcomes for primary malignant
melanoma of the esophagus. Sci Rep. 6:238042016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu H, Huang XY, Li Y, Xie X, Zhou JL,
Zhang LJ, Fu JH and Wang X: Primary malignant melanoma of the
esophagus: A study of clinical features, pathology, management and
prognosis. Dis Esophagus. 24:109–113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng J, Mo H, Ma S and Wang Z:
Clinicopathological findings of primary esophageal malignant
melanoma: Report of six cases and review of literature. Int J Clin
Exp Pathol. 7:7230–7235. 2014.PubMed/NCBI
|
|
6
|
Makuuchi H, Takubo K, Yanagisawa A and
Yamamoto S: Esophageal malignant melanoma: Analysis of 134 cases
collected by the Japan Esophageal Society. Esophagus. 12:158–169.
2015. View Article : Google Scholar
|
|
7
|
Inadomi K, Kumagai H, Arita S, Tsuruta N,
Takayoshi K, Mishima K, Ota S, Tanaka M, Okumura Y, Sagara K, et
al: Bi-cytopenia possibly induced by anti-PD-1 antibody for primary
malignant melanoma of the esophagus: A case report. Medicine
(Baltimore). 95:e42832016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sobin LH, Gospodarowicz M and Wittekind C:
TNM Classification of Malignant Tumors, 7th edition.
Wiley-Blackwell; Oxford: 2009
|
|
9
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Japan Esophageal Society: Japanese
Classification of Esophageal Cancer, 11th edition: Part I.
Esophagus. 14:1–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Makino T, Yamasaki M, Tanaka K, Masuike Y,
Tatsumi M, Motoori M, Kimura Y, Hatazawa J, Mori M and Doki Y:
Metabolic tumor volume change predicts long-term survival and
histological response to preoperative chemotherapy in locally
advanced esophageal cancer. Ann Surg. May 1–2018.(Epub ahead of
print). doi: 10.1097/SLA.0000000000002808. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Makino T, Miyata H, Yamasaki M, Fujiwara
Y, Takiguchi S, Nakajima K, Higuchi I, Hatazawa J, Mori M and Doki
Y: Utility of response evaluation to neo-adjuvant chemotherapy by
(18)F-fluorodeoxyglucose-positron emission tomography in locally
advanced esophageal squamous cell carcinoma. Surgery. 148:908–918.
2010. View Article : Google Scholar : PubMed/NCBIPubMed/NCBI
|
|
13
|
Ueda E, Kishimoto S and Yasuno H:
Statistical survey from 1982 to 1991 of 49 patients with malignant
melanocytic tumors. J Dermatol. 22:467–474. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Makino T, Yamasaki M, Miyazaki Y, Wada N,
Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M and Doki
Y: Utility of initial induction chemotherapy with 5-fluorouracil,
cisplatin, and docetaxel (DCF) for T4 esophageal cancer: A
propensity score-matched analysis. Dis Esophagus. 31:2018.doi:
10.1093/dote/dox130. View Article : Google Scholar
|
|
15
|
Makino T, Yamasaki M, Tanaka K, Tatsumi M,
Takiguchi S, Hatazawa J, Mori M and Doki Y: Importance of positron
emission tomography for assessing the response of primary and
metastatic lesions to induction treatments in T4 esophageal cancer.
Surgery. 162:836–845. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamasaki M, Miyata H, Fujiwara Y,
Takiguchi S, Nakajima K, Kurokawa Y, Mori M and Doki Y: Minimally
invasive esophagectomy for esophageal cancer: Comparative analysis
of open and hand-assisted laparoscopic abdominal lymphadenectomy
with gastric conduit reconstruction. J Surg Oncol. 104:623–628.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chalkiadakis G, Wihlm JM, Morand G,
Weill-Bousson M and Witz JP: Primary malignant melanoma of the
esophagus. Ann Thorac Surg. 39:472–475. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oshiro T, Shimoji H, Matsuura F, Uchima N,
Kinjo F, Nakayama T and Nishimaki T: Primary malignant melanoma of
the esophagus arising from a melanotic lesion: Report of a case.
Surg Today. 37:671–675. 2007.
|
|
19
|
Bisceglia M, Perri F, Tucci A, Tardio M,
Panniello G, Vita G and Pasquinelli G: Primary malignant melanoma
of the esophagus: A clinicopathologic study of a case with
comprehensive literature review. Adv Anat Pathol. 18:235–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sabanathan S, Eng J and Pradhan GN:
Primary malignant melanoma of the esophagus. Am J Gastroenterol.
84:1475–1481. 1989.PubMed/NCBI
|
|
21
|
Stranks GJ, Mathai JT and Rowe-Jones DC:
Primary malignant melanoma of the oesophagus: Case report and
review of surgical pathology. Gut. 32:828–830. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Topalian SL, Sznol M, McDermott DF, Kluger
HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB,
Powderly JD, et al: Survival, durable tumor remission, and
long-term safety in patients with advanced melanoma receiving
nivolumab. J Clin Oncol. 32:1020–1030. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weber JS, D'Angelo SP, Minor D, Hodi FS,
Gutzmer R, Neyns B, Hoeller C, Khushalani NI, Miller WH Jr, Lao CD,
et al: Nivolumab versus chemotherapy in patients with advanced
melanoma who progressed after anti-CTLA-4 treatment (CheckMate
037): A randomised, controlled, open-label, phase 3 trial. Lancet
Oncol. 16:375–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Robert C, Long GV, Brady B, Dutriaux C,
Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C,
Kalinka-Warzocha E, et al: Nivolumab in previously untreated
melanoma without BRAF mutation. N Engl J Med. 372:320–330. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rochefort P, Roussel J, de la Fouchardière
A, Sarabi M, Desseigne F, Guibert P, Cattey-Javouhey A, Mastier C,
Neidhardt-Berard EM and de la Fouchardière C: Primary malignant
melanoma of the esophagus, treated with immunotherapy: A case
report. Immunotherapy. 10:831–835. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sasaki K, Uchikado Y, Omoto I, Amatatsu M,
Megumi K, Okumura H, Maemura K and Natsugoe S: Multidisciplinary
therapy for metastatic primary malignant melanoma of the esophagus:
A case report. Mol Clin Oncol. 8:533–538. 2018.PubMed/NCBI
|
|
27
|
Lohmann CM, Hwu WJ, Iversen K, Jungbluth
AA and Busam KJ: Primary malignant melanoma of the oesophagus: A
clinical and pathological study with emphasis on the
immunophenotype of the tumours for melanocyte differentiation
markers and cancer/testis antigens. Melanoma Res. 13:595–601. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li B, Lei W, Shao K, Zhang C, Chen Z, Shi
S and He J: Characteristics and prognosis of primary malignant
melanoma of the esophagus. Melanoma Res. 17:239–242. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang S, Tachimori Y, Hokamura N, Igaki H,
Kishino T and Kushima R: Diagnosis and surgical outcomes for
primary malignant melanoma of the esophagus: A single-center
experience. Ann Thorac Surg. 96:1002–1006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Harada K, Mine S, Yamada K, Shigaki H, Oya
S, Baba H and Watanabe M: Long-term outcome of esophagectomy for
primary malignant melanoma of the esophagus: A single-institute
retrospective analysis. Dis Esophagus. 29:314–319. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun H, Gong L, Zhao G, Zhan H, Meng B, Yu
Z and Pan Z: Clinicopathological characteristics, staging
classification, and survival outcomes of primary malignant melanoma
of the esophagus. J Surg Oncol. 117:588–596. 2018. View Article : Google Scholar : PubMed/NCBI
|
